<DOC>
	<DOC>NCT00000301</DOC>
	<brief_summary>The purpose of this study is to empirically test a series of medications to: 1) determine each medication's efficacy in treatment of cocaine abuse/dependence; 2) find most effective dose range for each medication. In this study, amantadine is tested."</brief_summary>
	<brief_title>Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4</brief_title>
	<detailed_description>16-week participation plus a 2 weekk lead-in period. Participants are assigned randomly to placebo or amantadine. Participants attend group meeting 3 times/week</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Amantadine</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>M/F, ages 1865. cocaine dependence according to DMSIV criteria. Selfreported use within the last 30 days. Agreeable to conditions of the study and signed informed consent. Psychiatric disorder that requires medication therapy, history of seizures. Pregnant and/or nursing women. Dependence on ETOH or benzodiazepines or other sedativehypnotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Amantadine</keyword>
	<keyword>Cocaine</keyword>
	<keyword>Pharmacotherapy</keyword>
	<keyword>Outpatient</keyword>
</DOC>